rel-(1R,2R)-2-(2-Bromophenyl)cyclopropane-1-carboxylic acid

Catalog No. :
ACLKYW128
CAS No. :
175168-70-4
Molecular Formula :
C10H9BrO2
Molecular Weight :
241.08

IUPAC Name:(1R,2R)-2-(2-bromophenyl)cyclopropane-1-carboxylic acid

rel-(1R,2R)-2-(2-Bromophenyl)cyclopropane-1-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$70.00Login to see priceInquiryInquiry
1g97%$186.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namerel-(1R,2R)-2-(2-Bromophenyl)cyclopropane-1-carboxylic acid
IUPAC Name(1R,2R)-2-(2-bromophenyl)cyclopropane-1-carboxylic acid
MDL No.MFCD29049179
Molecular FormulaC10H9BrO2
Molecular Weight241.08
SMILESO=C([C@H]1[C@H](C2=CC=CC=C2Br)C1)O
InChI KeySJXGNJABBYVEHY-JGVFFNPUSA-N
Synonymrel-(1R,2R)-2-(2-Bromophenyl)cyclopropane-1-carboxylic acid;Cyclopropanecarboxylic acid, 2-(2-bromophenyl)-, (1R,2R)-rel-;rel-(1S,2S)-2-(2-Bromophenyl)cyclopropane-1-carboxylic acid;trans-2-(2-Bromophenyl)cyclopropane-1-carboxylic acid;trans-2-(2-Bromophenyl)cyclopropanecarboxylic Acid;(2S)-2-(2-bromophenyl)cyclopropane-1-carboxylic acid
CAS No.175168-70-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLKYW128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLKYW128 route product structure diagram
    ACLKYW128175168-70-4
Inquiry

2. ACLKYW128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLKYW128 route product structure diagram
    ACLKYW128175168-70-4
Inquiry

Comments (0)